Enveric Biosciences (ENVB) Net Margin (2014 - 2020)
Enveric Biosciences (ENVB) posted Net Margin of -12.62% for Q3 2020, down 11.91 percentage points from -0.72% a year earlier but up 7.75 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Net Margin (2014 - 2020) Analysis & Trends
For the trailing twelve months through Sep 30, 2020, Net Margin at Enveric Biosciences was -20.57%, up 35.98 percentage points year-over-year; for FY2019, it came in at -15.12%, up 30.19 percentage points from FY2018.
- Annual Net Margin shows a four-year change of -11.10 percentage points (FY2015 to FY2019).
- In prior years, Enveric Biosciences' Net Margin was -45.31% in FY2018 (-22.33 pp), -22.97% in FY2017 (-15.28 pp), -7.69% in FY2016 (-3.68 pp) and -4.02% in FY2015.
- Quarterly Net Margin has run from a low of -193.23% in Q4 2018 to a high of 36.71% in Q3 2018 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last three quarters, with an average year-over-year change of -9.18 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2019, with a gain of 164.11 percentage points; the weakest was Q4 2018, with a drop of 179.71 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -20.37% (Q2 2020), -19.71% (Q1 2020) and -29.12% (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -12.62% |
| Jun 30, 2020 | -20.37% |
| Mar 31, 2020 | -19.71% |
| Dec 31, 2019 | -29.12% |
| Sep 30, 2019 | -0.72% |
| Jun 30, 2019 | -12.37% |
| Mar 31, 2019 | -18.39% |
| Dec 31, 2018 | -193.23% |
| Sep 30, 2018 | 36.71% |
| Jun 30, 2018 | -12.32% |
| Mar 31, 2018 | -19.25% |
| Dec 31, 2017 | -13.52% |
| Sep 30, 2017 | -36.79% |
| Jun 30, 2017 | -30.85% |
| Mar 31, 2017 | -9.90% |
| Dec 31, 2016 | 10.51% |
| Sep 30, 2016 | -17.67% |
| Jun 30, 2016 | -18.08% |
| Mar 31, 2016 | -16.54% |
| Dec 31, 2015 | -24.30% |
API Access
Enveric Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();